BMO maintains outperform on Eli Lilly shares amid SURMOUNT-OSA data release - Investing.com Nigeria
Lilly OSA results 'small net-positive' for Inspire Medical, says Morgan Stanley - TipRanks.com - TipRanks
Tirzepatide Significantly Reduces OSA Symptoms in Phase 3 Trials, Lilly Looks Toward Mid-2024 Regulatory Submission - Patient Care Online
Tirzepatide improves sleep apnea symptoms for adults with OSA plus obesity - Healio
KeyBanc views Lilly's SURMOUNT-OSA results as 'a bit of a relief' for Inspire - TipRanks.com - TipRanks
Desktop versie